Alzheimer's disease (AD) is prevalent throughout the world and is the leading cause of
dementia in older individuals (aged≥ 65 years). To gain a deeper understanding of the …

Abstract Alzheimer's disease (AD), the most common neurodegenerative disorder, is
characterized by memory loss and cognitive dysfunction. The accumulation of misfolded …

Mild cognitive impairment (MCI) is the early stage of cognitive impairment between the
expected cognitive decline of normal aging and the more serious decline of dementia. This …

Background Epidemiological studies of mild cognitive impairment (MCI) and subtypes of
MCI have rarely focused on rural residents in China. Methods This population‐based study …

Mild cognitive impairment (MCI) is common in patients with hypertension. Prevalence
estimates of MCI in hypertensive patients are needed to guide both public health and clinical …

Herpes simplex virus type 1 (HSV-1) as a possible infectious etiology in Alzheimer's disease
(AD) has been proposed since the 1980s. The accumulating research thus far continues to …

Background The association between the instrumental activities of daily living (IADL) score
and the risk of initial cognitive function impairment is inconclusive. We aimed to identify …

Objectives There has been growing interest in the links between physical frailty and
cognitive impairment: both can increase the risk of emerging life-threatening health …

Cholinesterase inhibitors are a group of medicines that are widely used for the treatment of
cognitive impairments accompanying Alzheimer's disease as well as for the treatment of …

Importance Recent literature suggests there may be a significant effect of the vestibular
system on cognition and visuospatial processing. Given the increasing prevalence of …